Charles River Laboratories International Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600PRNewsWire • 05/10/21
Charles River Labs International Joins Elite List Of Stocks With 95-Plus Composite RatingInvestors Business Daily • 05/05/21
Charles River Laboratories International, Inc. (CRL) CEO Jim Foster on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/04/21
Three Scorching Medical Stocks To Watch, Including One Near A Buy PointInvestors Business Daily • 04/23/21
Charles River Laboratories International Inc (CRL) Corporate Executive VP & CFO David Ross.GuruFocus • 04/16/21
Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference CallBusiness Wire • 04/13/21
Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design CapabilitiesBusiness Wire • 04/06/21
Charles River Laboratories Announces Planned Offering of $1 Billion of Senior NotesBusiness Wire • 03/08/21
Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology StudiesBusiness Wire • 02/25/21
Charles River Laboratories International, Inc. (CRL) CEO Jim Foster on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/17/21
Charles River Laboratories (CRL) Beats Q4 Earnings and Revenue EstimatesZacks Investment Research • 02/17/21
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 GuidanceBusiness Wire • 02/17/21
Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy DevelopmentBusiness Wire • 02/17/21
Algernon Pharmaceuticals inks deal with Charles River Laboratories for preclinical work on DMT for strokeProactive Investors • 02/08/21
Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug ScreeningBusiness Wire • 01/28/21
Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference CallBusiness Wire • 01/20/21